Beckman Coulter launches SARS-CoV-2 IgG II antibody test in countries accepting CE Mark

16 Feb 2021

Read More
Beckman Coulter has launched its Access SARS-CoV-2 IgG II assay
 
Contact Beckman Coulter (UK) Ltd
 

Related Articles

The DxH 560 AL

Bringing large-scale haematology benefits to smaller labs

Added: 16 Feb 2021

Beckman Coulter has launched the DxH 560 AL, a tabletop analyser, designed to reduce the time and r…

World Sepsis Day is 13 September

World Sepsis Day on September 13 – faster identification of sepsis from Beckman Coulter Indicator

Added: 11 Sep 2020

Marking Word Sepsis Day this month, Beckman Coulter supports hospitals and laboratories in their ef…

SARS-CoV-2 IgG assay is available in markets accepting the CE Mark.

Access SARS-CoV-2 IgM assay available in markets accepting the CE Mark

Added: 22 Jun 2020

Beckman Coulter’s Access SARS-CoV-2 IgG assay is now available in markets accepting the CE Mark.